Research Study in Patients With Advanced Ovarian Epithelial Cancer

Withdrawn before enrolling

Conditions studied: Ovarian Serous Cystadenocarcinoma, Ovarian Serous Surface Papillary Adenocarcinoma, Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer, Stage IV Ovarian Cancer

In brief

This research trial studies tissue samples from patients with ovarian cancer in the laboratory. Analyzing tissue samples from patients in the laboratory may help doctors learn more about cancer.

Key facts

Study ID

NCT00053235

Run by

Gynecologic Oncology Group

People needed

0

Starts

2002-11-01

Last updated by the study team

2015-06-01

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Stage III or IV, high-grade (grade 2 or 3) ovarian cancers
• No borderline or low-grade (grade 1) tumors
• Tissue from predominately serous ovarian cancer only
• No clear cell, endometrioid, mucinous, transitional cell, or mixed without predominant serous component
• Tissue obtained during prior optimal or suboptimal cytoreductive surgery
• Must be enrolled on GOG-0136 and a GOG front-line paclitaxel/platinum chemotherapy trial
• Frozen tissue and hematoxylin-eosin stained section from the ovary obtained at initial surgery
• Performance status - GOG 0-2

Where it is running

• Gynecologic Oncology Group — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.